Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares rose in value on Monday February 13 on lighter trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.
Meanwhile U.S. stock-market indexes opened higher on Monday, setting intraday all-time highs shortly after market open. The S&P 500 SPX, +0.35% opened up 6 points, or 0.2%, at 2,322.
The Nasdaq Composite COMP, +0.44% began the session up 18 points, or 0.3% higher at 5,752. The Dow Jones Industrial Average DJIA, +0.51% added 64 points or 0.3%, to 20,340 at the open.
Analysts at Piper Jaffray Companies upgraded shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) from Neutral to Overweight today. Piper Jaffray Companies currently has a rating of Overweight on the shares. As a means of comparison, a number of other analysts have commented on the company recently, and Regeneron Pharmaceuticals, Inc. has secured a consensus one-year price target of $422.68, higher than the opening price of $364.22, a difference of 11.50 percent. Regeneron Pharmaceuticals, Inc. stock has a 52-week high of $452.96. Share prices sometimes get a bounce to the upside when analysts upgrade a stock.
Yesterday Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares last traded at $367.64, which represents a jump of $7.77 compared to the previous closing price. Opening at $364.22, they fluctuated from $363.20 and $367.64 throughout the day.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) now has a market cap of 38.64B.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Average Daily Trading Volume
214,991 shares traded hands yesterday, 110 percent below the average, out of a total float 77,881,000. lower than normal. Look for trading volume to pick up in the coming days as investors often use swings in trading volume to identify heavy volume accumulation or distribution by institutional investors.
While increased trading for short periods will not mean much will not mean much, however, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.
Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.
Institutional investors such as these retain teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Moving Averages
A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.
This is because the average acts like a floor (support), so the price bounces up off of it.
In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.
By identifying trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.
With that in mind, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) now has a 50-day MA of $363.18 and 200-day MA of $386.48. It has traded in a 52-week range between $325.35 – 452.96 and today’s last price is 18.84%% lower than the 52 week high of $452.96.
Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors seek companies that have increased their earnings at least 25% or more over 3 consecutive years.
DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.